AAMP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.659600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.944400E-02
Normal-vs-Stage2
6.940100E-02
Normal-vs-Stage3
6.424600E-01
Normal-vs-Stage4
8.544900E-03
Stage1-vs-Stage2
6.671200E-01
Stage1-vs-Stage3
4.506800E-01
Stage1-vs-Stage4
3.348400E-01
Stage2-vs-Stage3
1.713240E-01
Stage2-vs-Stage4
6.025000E-01
Stage3-vs-Stage4
2.361800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.970100E-02
Normal-vs-AfricanAmerican
1.249190E-01
Normal-vs-Asian
1.815880E-03
Caucasian-vs-AfricanAmerican
9.077200E-01
Caucasian-vs-Asian
5.561600E-02
AfricanAmerican-vs-Asian
3.806800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.683600E-02
Normal-vs-Female
1.081950E-01
Male-vs-Female
2.021200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.225200E-01
Normal-vs-Age(41-60Yrs)
1.714220E-02
Normal-vs-Age(61-80Yrs)
1.363470E-04
Normal-vs-Age(81-100Yrs)
1.503940E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.281400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.175200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.178000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.366000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.829800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.403000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.156650E-03
Normal-vs-Daily Drinker
2.048000E-04
Normal-vs-Weekly Drinker
3.063000E-03
Normal-vs-Occasional Drinker
2.101800E-03
Normal-vs-Social Drinker
1.034040E-01
Non Drinker-vs-Daily Drinker
4.678400E-01
Non Drinker-vs-Weekly Drinker
3.845000E-01
Non Drinker-vs-Occasional Drinker
4.566300E-02
Non Drinker-vs-Social Drinker
5.860000E-01
Daily Drinker-vs-Weekly Drinker
7.843000E-01
Daily Drinker-vs-Occasional Drinker
2.734800E-01
Daily Drinker-vs-Social Drinker
2.229800E-01
Weekly Drinker-vs-Occasional Drinker
5.574200E-01
Weekly Drinker-vs-Social Drinker
1.976030E-01
Occasional Drinker-vs-Social Drinker
5.800500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.528000E-02
Normal-vs-Grade 2
8.421100E-03
Normal-vs-Grade 3
1.958620E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.140600E-03
Grade 1-vs-Grade 3
2.335100E-03
Grade 1-vs-Grade 4
5.528000E-02
Grade 2-vs-Grade 3
9.906400E-01
Grade 2-vs-Grade 4
8.421100E-03
Grade 3-vs-Grade 4
1.958620E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.178250E-04
Normal-vs-NonDiabetic
5.320100E-02
Diabetic-vs-NonDiabetic
3.744600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.518000E-03
Normal-vs-NoPancreatitis
9.036300E-02
Pancreatitis-vs-NoPancreatitis
1.046210E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.186400E-02
Normal-vs-N1
7.728300E-02
N0-vs-N1
6.847800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.084600E-03
Normal-vs-TP53-NonMutant
2.547400E-01
TP53-Mutant-vs-TP53-NonMutant
7.0876000002329E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
